Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice
Open accessThe DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Abstract
OBJECTIVE—Diabetes and obesity are characterized by a low-grade inflammation whose molecular origin is unknown. We previously determined, first, that metabolic endotoxemia controls the inflammatory tone, body weight gain, and diabetes, and second, that high-fat feeding modulates gut microbiota and the plasma concentration of lipopolysaccharide (LPS), i.e., metabolic endotoxemia. Therefore, it remained to demonstrate whether changes in gut microbiota control the occurrence of metabolic diseases. RESEARCH DESIGN AND METHODS—We changed gut microbiota by means of antibiotic treatment to demonstrate, first, that changes in gut microbiota could be responsible for the control of metabolic endotoxemia, the low-grade inflammation, obesity, and type 2 diabetes and, second, to provide some mechanisms responsible for such effect. RESULTS—We found that changes of gut microbiota induced by an antibiotic treatment reduced metabolic endotoxemia and the cecal content of LPS in both high-fat–fed and ob/ob mice. This effect was correlated with reduced glucose intolerance, body weight gain, fat mass development, lower inflammation, oxidative stress, and macrophage infiltration marker mRNA expression in visceral adipose tissue. Importantly, high-fat feeding strongly increased intestinal permeability and reduced the expression of genes coding for proteins of the tight junctions. Furthermore, the absence of CD14 in ob/ob CD14−/− mutant mice mimicked the metabolic and inflammatory effects of antibiotics. CONCLUSIONS—This new finding demonstrates that changes in gut microbiota controls metabolic endotoxemia, inflammation, and associated disorders by a mechanism that could increase intestinal permeability. It would thus be useful to develop strategies for changing gut microbiota to control, intestinal permeability, metabolic endotoxemia, and associated disorders.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Bacterial translocation can be defined as the passage of bacteria, or bacterial products such as LPS, into the portal circulation and happens when the complex regulation of the mechanisms of the gut barrier is lost [276], which has been linked with the occurrence of NAFLD, NASH, hepatic fibrosis, and HCC in several rodent models [227,228,277].”
From Gut-pancreas-liver Axis as a target for treatment of NAFLD/NASH (2020) · cites this paper as [276]
In the citing paper
“Penetration of lipopolysaccharide into the bloodstream is controlled by the integrity of the gut barrier.”
From Akkermansia Muciniphila Protects Against Atherosclerosis by Preventing Metabolic Endotoxemia-Induced Inflammation in Apoe −/− Mice (2016) · cites this paper as [48]
In the citing paper
“In obese rodents, antibiotics and prebiotics were able to restore gut barrier integrity and metabolic functions, providing evidence for the gut barrier as a mediator of microbiota-induced systemic inflammation [98,99].”
Citations
Cites
1 retracted
Tsukumo, D. M. L., Carvalho-Filho, M. A., Carvalheira, J. B. C., Prada, P. O., Hirabara, S. M., Schenka, A. A., Araújo, E. P., Vassallo, J., Curi, R., Velloso, L. A., et al. (2007) · Diabetes · doi:10.2337/db06-1595 · Cited by 826 · cited 3×
“We and others have recently demonstrated that the mechanisms of highfat diet-induced inflammation and metabolic disorders were clearly linked to LPS (4;24-28).”
BackgroundResultRetractedAn obesity-associated gut microbiome with increased capacity for energy harvest
Turnbaugh, P. J., Ley, R. E., Mahowald, M. A., Magrini, V., Mardis, E. R., & Gordon, J. I. (2006) · Nature · doi:10.1038/nature05414 · Cited by 12,444
Obesity is associated with macrophage accumulation in adipose tissue
Weisberg, S. P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R. L., & Ferrante, A. W. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319246 · Cited by 10,041 · cited 7×
“Inflammation: PAI-1, IL-1, and TNF- mRNA concentrations (A, D and G); oxidative stress: STAMP-2 and NADPHox mRNA concentrations (B and E); macrophage infiltration markers: MCP-1 and F4/80 mRNA concentrations (C and F) in mice fed normal diet (CT), normal diet and antibiotics (CT-Ab), high-fat diet (HF), or high-fat di…”
ResultInfluentialInflammation and metabolic disorders
Hotamisligil, G. S. (2006) · Nature · doi:10.1038/nature05485 · Cited by 9,199 · cited 1×
“Diabetes and obesity are characterized by a low-grade inflammation whose molecular origin is unknown (2,3).”
BackgroundHuman gut microbes associated with obesity
Ley, R. E., Turnbaugh, P. J., Klein, S., & Gordon, J. I. (2006) · Nature · doi:10.1038/4441022a · Cited by 8,785 · cited 2×
“Gut microbiota has recently been proposed as an environmental factor involved in the control of body weight and energy homeostasis (7-12).”
BackgroundResultMetabolic Endotoxemia Initiates Obesity and Insulin Resistance
Cani, P. D., Amar, J., Iglesias, M. A., Poggi, M., Knauf, C., Bastelica, D., Neyrinck, A. M., Fava, F., Tuohy, K. M., Chabo, C., et al. (2007) · Diabetes · doi:10.2337/db06-1491 · Cited by 6,638 · cited 16×
“Although the reasons for its increase in plasma during high-fat feeding were undetermined, its levels were closely correlated but not causatively demonstrated, with changes in intestinal microbiota where the Gram negative–to–Gram positive ratio increased during high-fat feeding (4).”
BackgroundMethodResultSelf-citationThe gut microbiota as an environmental factor that regulates fat storage
Bäckhed, F., Ding, H., Wang, T., Hooper, L. V., Koh, G. Y., Nagy, A., Semenkovich, C. F., & Gordon, J. I. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407076101 · Cited by 6,245 · cited 1×
“Germ-free mice of the same age and genetic background as conventional mice fed with a normal chow diet had a 40% lower weight (11), whereas germ-free mice colonized with the gut microbiota derived from the conventional mice increased their fat mass and developed insulin resistance within 2 weeks.”
BackgroundObesity alters gut microbial ecology
Ley, R. E., Bäckhed, F., Turnbaugh, P., Lozupone, C. A., Knight, R. D., & Gordon, J. I. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504978102 · Cited by 6,176 · cited 1×
“These animals are characterized by different gut microbiota (8,12), higher inflammatory tone, and endotoxemia when compared with wild-type mice (23).”
BackgroundIncreased oxidative stress in obesity and its impact on metabolic syndrome
Furukawa, S., Fujita, T., Shimabukuro, M., Iwaki, M., Yamada, Y., Nakajima, Y., Nakayama, O., Makishima, M., Matsuda, M., & Shimomura, I. (2004) · Journal of Clinical Investigation · doi:10.1172/jci21625 · Cited by 5,508 · cited 2×
“Oxidative stress is frequently associated with inflammation and metabolic dysfunction in adipose depots (20-22).”
BackgroundMechanisms linking obesity to insulin resistance and type 2 diabetes
Kahn, S. E., Hull, R. L., & Utzschneider, K. M. (2006) · Nature · doi:10.1038/nature05482 · Cited by 5,448 · cited 1×
“Diabetes 57:1470–1481, 2008 Environmental factors, such as a fat-enriched diet and a sedentary lifestyle, are the causes of the great prevalence of obesity and type 2 diabetes in the population (1).”
Background
Cited by
Items 901–1,000 of 1,065
Caenorhabditis elegans: a model to understand host–microbe interactions
Kumar, A., Baruah, A., Tomioka, M., Iino, Y., Kalita, M. C., & Khan, M. R. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03319-7 · Cited by 139
Metabolic endotoxemia promotes neuroinflammation after focal cerebral ischemia
Kurita, N., Yamashiro, K., Kuroki, T., Tanaka, R., Urabe, T., Ueno, Y., Miyamoto, N., Takanashi, M., Shimura, H., Inaba, T., et al. (2020) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x19899577 · Cited by 127
“Although interspecies differences should always be considered, the murine gut has successfully been used as a model to investigate the role of gut microbiota in complex human disorders, including post-stroke infections, obesity, and diabetes.(8,19) The present study had some limitations.”
BackgroundMethodInfluentialKarlsson, C., Ahrné, S., Molin, G., Berggren, A., Palmquist, I., Fredrikson, G. N., & Jeppsson, B. W. (2009) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2009.06.019 · Cited by 126
“Pro-inflammatory components of the resident microbiota can increase the permeability of the mucosal barrier and cause subclinical inflammation [7].”
BackgroundThe microbiota and its metabolites in colonic mucosal health and cancer risk
Vipperla, K., & O'Keefe, S. J. (2012) · Nutrition in Clinical Practice · doi:10.1177/0884533612452012 · Cited by 116
Brain inflammation and hypertension: the chicken or the egg?
Winklewski, P. J., Radkowski, M., Wszedybyl-Winklewska, M., & Demkow, U. (2015) · Journal of Neuroinflammation · doi:10.1186/s12974-015-0306-8 · Cited by 116
“This reaction is comparable to low-grade systemic inflammation elicited by periodontal bacteria or a hyperlipidic diet [69-72].”
BackgroundObesity-induced cognitive impairment in older adults: a microvascular perspective
Balasubramanian, P., Kiss, T., Tarantini, S., Nyúl-Tóth, Á., Ahire, C., Yabluchanskiy, A., Csipo, T., Lipecz, A., Tabak, A., Institoris, A., et al. (2021) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00736.2020 · Cited by 115
Khor, B., Snow, M., Herrman, E., Ray, N., Mansukhani, K., Patel, K. A., Said-Al-Naief, N., Maier, T., & Machida, C. A. (2021) · Microorganisms · doi:10.3390/microorganisms9030496 · Cited by 115
“In addition, high‐fat diets downregulate the tight junction pro‐ teins occludin and ZO‐1, increasing intestinal permeability [27].”
BackgroundMicrobiota–gut–brain axis: interplay between microbiota, barrier function and lymphatic system
Zhuang, M., Zhang, X., & Cai, J. (2024) · Gut Microbes · doi:10.1080/19490976.2024.2387800 · Cited by 139
“14,15 16–18 Moreover, disruption of gut vascular barrier disruption due to an inflammatory insult induces closure of the choroid plexus vascular barrier in mice, suggesting a functional link between barriers along the gut – brain axis, which might be responsible for the commonly concurrent…”
BackgroundComplement Factor H Is Expressed in Adipose Tissue in Association With Insulin Resistance
Moreno-Navarrete, J. M., Martínez-Barricarte, R., Catalán, V., Sabater, M., Gómez-Ambrosi, J., Ortega, F. J., Ricart, W., Blüher, M., Frühbeck, G., Rodríguez de Cordoba, S., et al. (2010) · Diabetes · doi:10.2337/db09-0700 · Cited by 116
“High fat diet has been recently described to raise endotoxin translocation from the gut into the bloodstream, leading to endotoxin-induced metabolic alterations named as metabolic endotoxemia (46,47).”
BackgroundGut Microbiome as a Potential Factor for Modulating Resistance to Cancer Immunotherapy
Shui, L., Yang, X., Li, J., Yi, C., Sun, Q., & Zhu, H. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02989 · Cited by 115
Metformin: old friend, new ways of action–implication of the gut microbiome?
Rodriguez, J., Hiel, S., & Delzenne, N. M. (2018) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0000000000000468 · Cited by 137
Self-citationHigh-Fat Diet Consumption Induces Microbiota Dysbiosis and Intestinal Inflammation in Zebrafish
Arias-Jayo, N., Abecia, L., Alonso‐Sáez, L., Ramirez‐Garcia, A., Rodriguez, A., & Pardo, M. Á. (2018) · Microbial Ecology · doi:10.1007/s00248-018-1198-9 · Cited by 124
Sanguinetti, E., Collado, M. C., Marrachelli, V. G., Monleon, D., Selma-Royo, M., Pardo-Tendero, M. M., Burchielli, S., & Iozzo, P. (2018) · Scientific Reports · doi:10.1038/s41598-018-23261-1 · Cited by 115
Metabolic Syndrome During Perinatal Period in Sows and the Link With Gut Microbiota and Metabolites
Cheng, C., Wei, H., Yu, H., Xu, C., Jiang, S., & Peng, J. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.01989 · Cited by 121
Pancreatic cancer associated with obesity and diabetes: an alternative approach for its targeting
Pothuraju, R., Rachagani, S., Junker, W. M., Chaudhary, S., Saraswathi, V., Kaur, S., & Batra, S. K. (2018) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-018-0963-4 · Cited by 130
Heiss, C. N., Mannerås-Holm, L., Lee, Y. S., Serrano-Lobo, J., Håkansson Gladh, A., Seeley, R. J., Drucker, D. J., Bäckhed, F., & Olofsson, L. E. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109163 · Cited by 114
Probiotics supplementation and insulin resistance: A systematic review
Salles, B. I. M., Cioffi, D., & Ferreira, S. R. G. (2020) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-020-00603-6 · Cited by 114
Diet Effects in Gut Microbiome and Obesity
Chen, J., He, X., & Huang, J. (2014) · Journal of Food Science · doi:10.1111/1750-3841.12397 · Cited by 114
Gholizadeh, P., Mahallei, M., Pormohammad, A., Varshochi, M., Ganbarov, K., Zeinalzadeh, E., Yousefi, B., Bastami, M., Tanomand, A., Mahmood, S. S., et al. (2018) · Microbial Pathogenesis · doi:10.1016/j.micpath.2018.11.031 · Cited by 124
Jones, R. B., Alderete, T. L., Kim, J. S., Millstein, J., Gilliland, F. D., & Goran, M. I. (2019) · Gut Microbes · doi:10.1080/19490976.2019.1592420 · Cited by 123
Combinatorial Effects of Diet and Genetics on Inflammatory Bowel Disease Pathogenesis
Dixon, L. J., Kabi, A., Nickerson, K. P., & McDonald, C. (2015) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000289 · Cited by 136
“sive intake of dietary fats also alters the intestinal microbiota, which can significantly impact intestinal permeability and inflammation.(17,20) Antibiotic treatment of mice on an HFD reduced metabolic endotoxemia and restored intestinal expression of tight junction proteins.”
BackgroundResultInfluentialLê, K., Li, Y., Xu, X., Yang, W., Liu, T., Zhao, X., Tang, Y. G., Cai, D., Go, V. L. W., Pandol, S., et al. (2013) · Frontiers in Physiology · doi:10.3389/fphys.2012.00496 · Cited by 131
“Although the mechanisms remain unknown, it has been speculated that modifications of the gut microbiota may increase local and plasma lipopolysaccharide (LPS), which may in turn lead to inflammation, hepatic fat accumulation, insulin resistance, and T2D (Cani et al., 2008).”
BackgroundInfluentialRodríguez-Carrio, J., López, P., Sánchez, B., González, S., Gueimonde, M., Margolles, A., de los Reyes-Gavilán, C. G., & Suárez, A. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00023 · Cited by 113
“Experimental studies with mice have revealed that diet-induced obesity is accompanied by changes in the gut microbiota and damaged intestinal barrier (67, 68).”
BackgroundJang, H., Han, S., Kim, J., Oh, S., Jang, H., & Kim, D. (2019) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201800978 · Cited by 113
Dietary lipids from body to brain
Custers, Emma, E. M., Kiliaan, & Amanda, J. K. (2021) · Progress in Lipid Research · doi:10.1016/j.plipres.2021.101144 · Cited by 122
The impact of maternal high-fat diet on offspring neurodevelopment
Urbonaite, G., Knyzeliene, A., Bunn, F. S., Smalskys, A., & Neniskyte, U. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.909762 · Cited by 110
“The HFD may influence the disruption of intestinal wall integrity by reducing the production of tight junction proteins (Cani et al., 2008).”
BackgroundCritical role of Kupffer cells in the management of diet-induced diabetes and obesity
Neyrinck, A. M., Cani, P. D., Dewulf, E. M., De Backer, F., Bindels, L. B., & Delzenne, N. M. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.05.070 · Cited by 114
“Are those effects relevant in pathological conditions such as development of metabolic disorders associated to obesity? In order to address this question, we induced obesity, impaired glucose tolerance, insulin resistance together with metabolic disorders (fat accumulation in adipose tissues and liver) in mice by feed…”
BackgroundSelf-citationMinami, J.-I., Kondo, S., Yanagisawa, N., Odamaki, T., Xiao, J.-Z., Abe, F., Nakajima, S., Hamamoto, Y., Saitoh, S., & Shimoda, T. (2015) · Journal of Nutritional Science · doi:10.1017/jns.2015.5 · Cited by 112
“Lipopolysaccharides (LPS) have been suggested to be involved in the development of metabolic syndromes associated with high fat intake((11,42,43)).”
Increased intestinal permeability to oral chromium (51Cr) ‐EDTA in human Type 2 diabetes
Horton, F., Wright, J., Smith, L., Hinton, P. J., & Robertson, M. D. (2014) · Diabetic Medicine · doi:10.1111/dme.12360 · Cited by 112
Changes of gut bacteria and immune parameters in liver transplant recipients
Wu, Z., Ling, Z., Lu, H., Zuo, J., Sheng, J., Zheng, S., & Li, L. (2012) · Hepatobiliary & pancreatic diseases international · doi:10.1016/s1499-3872(11)60124-0 · Cited by 117
Ejtahed, H., Soroush, A. R., Angoorani, P., Larijani, B. A., & Hasani‐Ranjbar, S. (2016) · Hormone and Metabolic Research · doi:10.1055/s-0042-107792 · Cited by 120
Improving obesity and blood pressure
Tanaka, M. (2019) · Hypertension Research · doi:10.1038/s41440-019-0348-x · Cited by 122
Gut Microbiota and Host Metabolism: From Proof of Concept to Therapeutic Intervention
Cani, P. D., Moens de Hase, E., & Van Hul, M. (2021) · Microorganisms · doi:10.3390/microorganisms9061302 · Cited by 112
“To bypass the limitations of the GF models, depletion of the microbiota of fully developed mice using broad-spectrum antibiotics has been used for many years [63].”
Self-citationHodin, C. M., Verdam, F. J., Grootjans, J., Rensen, S. S., Verheyen, F. K., Dejong, C. H., Buurman, W. A., Greve, J. W., & Lenaerts, K. (2011) · The Journal of Pathology · doi:10.1002/path.2917 · Cited by 111
“Since changes in the gut microbiota have been implicated in the obesity-associated increase in intestinal permeability and metabolic endotoxaemia, we hypothesize that disturbed Paneth cell function may underlie these phenomena [15,16].”
BackgroundDiet-induced obesity increases NF-κB signaling in reporter mice
Carlsen, H., Haugen, F., Zadelaar, S., Kleemann, R., Kooistra, T., Drevon, C. A., & Blomhoff, R. (2009) · Genes & Nutrition · doi:10.1007/s12263-009-0133-6 · Cited by 120
“Abdominal NF-jB activity may be due to immune cells invading the adipose tissue depots or an alteration of the microbial environment of the colon [ 25 , 26].”
Oliveira, A. G., Araujo, T. G., Carvalho, B. M., Guadagnini, D., Rocha, G. Z., Bagarolli, R. A., Carvalheira, J. B. C., & Saad, M. J. A. (2013) · Obesity · doi:10.1002/oby.20402 · Cited by 111
“Furthermore, it was demonstrated that fat intake leads to increased intestinal permeability for LPS (39).”
BackgroundGut microbiota and probiotics in maternal and infant health
Sanz, Y. (2011) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.110.001172 · Cited by 124
Wang, H. (2012) · World Journal of Gastroenterology · doi:10.3748/wjg.v18.i18.2180 · Cited by 111
Tian, P., Li, B., He, C., Song, W., Hou, A., Tian, S., Meng, X., Li, K., & Shan, Y. (2016) · Food & Function · doi:10.1039/c6fo00831c · Cited by 120
Prattichizzo, F., Giuliani, A., Mensa’, E., Sabbatinelli, J., Nigris, V. D., Rippo, M. R., Sala, L. L., Procopio, A. D., Olivieri, F., & Ceriello, A. (2018) · Ageing Research Reviews · doi:10.1016/j.arr.2018.10.003 · Cited by 122
Moludi, J., Maleki, V., Jafari‐Vayghyan, H., Vaghef‐Mehrabany, E., & Alizadeh, M. (2020) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.13250 · Cited by 111
Microbial enzymes induce colitis by reactivating triclosan in the mouse gastrointestinal tract
Zhang, J., Walker, M. E., Sanidad, K. Z., Zhang, H., Liang, Y., Zhao, E., Chacón-Vargas, K., Yeliseyev, V., Parsonnet, J., Haggerty, T. D., et al. (2022) · Nature Communications · doi:10.1038/s41467-021-27762-y · Cited by 121
Neutrophils Actively Contribute to Obesity-Associated Inflammation and Pathological Complications
Uribe‐Querol, E., & Rosales, C. (2022) · Cells · doi:10.3390/cells11121883 · Cited by 134
“A major bacterial product found to cross the intestinal barrier in obese individuals is lipopolysaccharide (LPS), which triggers innate immune cells, leading to inflammation [51,52].”
BackgroundLuoto, R., Kalliomäki, M., Laitinen, K., Delzenne, N. M., Cani, P. D., Salminen, S., & Isolauri, E. (2011) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0b013e3181f3457f · Cited by 111
“It is feasible that the ‘‘core microbiome,’’ with its metabolic effects on the host, is more important than the mere presence of a particular bacterial species (29), even though the Bifidobacterium microbiota has been shown to protect against gut barrier dysfunction (30), metabolic endotoxemia (8), insulin resistance…”
BackgroundSelf-citationNymark, M., Pussinen, P. J., Tuomainen, A. M., Forsblom, C., Groop, P.-H., Lehto, M., & on behalf of the FinnDiane Study Group (2009) · Diabetes Care · doi:10.2337/dc09-0467 · Cited by 111
Pachikian, B. D., Neyrinck, A. M., Deldicque, L., Backer, F. C. D., Catry, É., Dewulf, E. M., Sohet, F. M., Bindels, L. B., Everard, A., Francaux, M., et al. (2010) · Journal of Nutrition · doi:10.3945/jn.109.117374 · Cited by 115
“were quantified as described previously (19).”
BackgroundMethodSelf-citationSpreadbury, I. (2012) · Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy · doi:10.2147/dmso.s33473 · Cited by 111
High-fat diet causes psychiatric disorders in mice by increasing Proteobacteria population
Jeong, M.-Y., Jang, H.-M., & Kim, D.-H. (2019) · Neuroscience Letters · doi:10.1016/j.neulet.2019.01.006 · Cited by 110
Mao, B., Li, D., Zhao, J., Liu, X., Gu, Z., Chen, Y. Q., Zhang, H., & Chen, W. (2015) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf505156h · Cited by 113
Bai, J., Zhu, Y. G., & Dong, Y. (2016) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2016.10.043 · Cited by 124
“Evidences indicate that gut microbiota plays a pivotal role in obesity, obesity-associated inflammation, and insulin resistance (Cani et al., 2008; Tremaroli and Bäckhed, 2012; Zhao, 2013).”
BackgroundInfluentialHyperuricemia is associated with impaired intestinal permeability in mice
Xu, D., Lv, Q., Wang, X., Cui, X., Zhao, P., Yang, X., Liu, X., Yang, W. Q., Yang, G., Wang, G., et al. (2019) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00151.2019 · Cited by 117
Chen, T., & Yang, C. S. (2019) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2019.1654430 · Cited by 115
Fan, Y., Han, W., Zhan, G., Li, S., Jiang, X., Wang, L., Xiang, S., Zhu, B., Yang, L., Luo, A., et al. (2019) · Aging · doi:10.18632/aging.102469 · Cited by 124
“com 10462 AGING could secrete LPS endotoxins, finally leading to metabolic endotoxemia and increased levels of Bacteroidetes and Proteobacteria in patients with T2DM [20].”
BackgroundGut microbiota, epithelial function and derangements in obesity
Raybould, H. E. (2012) · The Journal of Physiology · doi:10.1113/jphysiol.2011.222133 · Cited by 110
“An increase in intestinal permeability and altered expression of tight junction proteins (ZO-1) has also been reported in response to HF feeding in mice (Cani et al. 2008) and humans (Osbak et al.”
BackgroundThe Gut Microbiome and Individual-Specific Responses to Diet
Leshem, A., Segal, E., & Elinav, E. (2020) · mSystems · doi:10.1128/msystems.00665-20 · Cited by 109
The modulatory role of high fat feeding on gastrointestinal signals in obesity
Duca, F. A., Sakar, Y., & Covașă, M. (2013) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2013.05.005 · Cited by 127
Role of Gut Microbiota in Obesity, Type 2 Diabetes and Alzheimer’s Disease
Naseer, M., Bibi, F., Alqahtani, M., Chaudhary, A., Azhar, E., Kamal, M., & Yasir, M. (2014) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/18715273113126660147 · Cited by 109
“Changing the gut microbiota of host by antibiotic treatment protects against diet-induced adiposity, oxidative stress, glucose intolerance, insulin resistance and low-grade inflammation [11, 36].”
BackgroundInfluentialCollins, B., Hoffman, J. B., Martinez, K., Grace, M. H., Lila, M. A., Cockrell, C., Nadimpalli, A., Chang, E. B., Chuang, C., Wei, Z., et al. (2016) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2015.12.021 · Cited by 124
“In contrast, other research has shown that feeding nonphysiological levels of saturated fat triggers intestinal inflammation that contribute to increase systemic inflammation and insulin resistance, possibly due to intestinal dysbiosis and barrier dysfunction [7–13,18,19,67–69].”
BackgroundResultGuevara‐Cruz, M., Godinez-Salas, E. T., Sánchez‐Tapia, M., Torres‐Villalobos, G., Pichardo‐Ontiveros, E., Guizar-Heredia, R., Arteaga-Sánchez, L., Gamba, G., Mojica-Espinoza, R., Schcolnik‐Cabrera, A., et al. (2020) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2019-000948 · Cited by 117
Arora, T., & Sharma, R. (2011) · Nutrition Reviews · doi:10.1111/j.1753-4887.2010.00365.x · Cited by 109
CD14 Modulates Inflammation-Driven Insulin Resistance
Fernández‐Real, J. M., Pérez‐del‐Pulgar, S., Luche, É., Moreno‐Navarrete, J. M., Waget, A., Sérino, M., Sorianello, E. M., Sánchez‐Pla, Á., Pontaque, F. C., Vendrell, J. J., et al. (2011) · Diabetes · doi:10.2337/db10-1210 · Cited by 126
“A two- to threefold increased plasma concentration of LPS has been demonstrated to constitute a sufficient molecular mechanism for triggering insulin resistance, obesity, and type 2 diabetes (18,28).”
BackgroundMethodSelf-citationLuche, E., Cousin, B., Garidou, L., Serino, M., Waget, A., Barreau, C., André, M., Valet, P., Courtney, M., Casteilla, L., et al. (2013) · Molecular Metabolism · doi:10.1016/j.molmet.2013.06.005 · Cited by 108
“In a first set of experiments mice were fed with either a normal chow diet (NC, energy content: 12% fat, 28% protein, and 60% carbohydrate, A04, Villemoisson sur Orge, France) or a high-fat carbohydrate-free diet which specifically induces metabolic endotoxemia (HFD, energy content: 72% fat, 28% protein and o1% carboh…”
MethodResultSelf-citationZhong, Y., Marungruang, N., Fåk, F., & Nyman, M. (2015) · British Journal of Nutrition · doi:10.1017/s0007114515000793 · Cited by 108
Wang, G., Jiao, T., Xu, Y., Li, D., Si, Q., Hao, J., Zhao, J., Zhang, H., & Chen, W. (2020) · Food & Function · doi:10.1039/c9fo02905b · Cited by 117
Rahimlou, M., Hosseini, S. A., Majdinasab, N., Haghighizadeh, M. H., & Husain, D. (2020) · Nutritional Neuroscience · doi:10.1080/1028415x.2020.1758887 · Cited by 119
“like behavior and depressive symptoms [23,24].”
BackgroundVinuesa, Á., Pomilio, C. J., Gregosa, A., Bentivegna, M., Presa, J., Bellotto, M., Saravia, F., & Beauquis, J. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.653651 · Cited by 122
Zhao, N., Chen, Q.-G., Chen, X., Liu, X.-T., Geng, F., Zhu, M.-M., Yan, F.-L., Zhang, Z.-J., & Ren, Q.-G. (2023) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2022.11.013 · Cited by 105
Metabolic diseases and pro- and prebiotics: Mechanistic insights
Nakamura, Y. K., & Omaye, S. T. (2012) · Nutrition & Metabolism · doi:10.1186/1743-7075-9-60 · Cited by 107
Aging and serum MCP-1 are associated with gut microbiome composition in a murine model
Conley, M. N., Wong, C. P., Duyck, K. M., Hord, N., Ho, E., & Sharpton, T. J. (2016) · PeerJ · doi:10.7717/peerj.1854 · Cited by 107
Mei, X., Zhang, X., Wang, Z., Gao, Z., Liu, G., Hu, H., Zou, L., & Li, X. (2016) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.6b03474 · Cited by 118
Kasahara, K., Tanoue, T., Yamashita, T., Yodoi, K., Matsumoto, T., Emoto, T., Mizoguchi, T., Hayashi, T., Kitano, N., Sasaki, N., et al. (2017) · Journal of Lipid Research · doi:10.1194/jlr.m072165 · Cited by 107
Perea, K., Perz, K., Olivo, S., Williams, A., Lachman, M., Ishaq, S. L., Thomson, J. M., & Yeoman, C. J. (2017) · Journal of Animal Science · doi:10.2527/jas.2016.1222 · Cited by 131
“…those suffering from inflammatory bowel disease (Mukhopadhya et al., 2012), diarrhea (Suchodolski et al., 2015), as well as obese individuals (Zhao, 2013), where endotoxin of the well-known Proteobacterial member, E. coli, has been shown to affect subcutaneous adiposity (Cani et al., 2008).”
BackgroundDepression and Obesity: Analysis of Common Biomarkers
Milano, W., Ambrosio, P., Carizzone, F., De Biasio, V., Di Munzio, W., Foia, M. G., & Capasso, A. (2020) · Diseases · doi:10.3390/diseases8020023 · Cited by 106
The Microbiota and the Gut–Brain Axis in Controlling Food Intake and Energy Homeostasis
Romaní‐Pérez, M., Bullich‐Vilarrubias, C., López‐Almela, I., Liébana-García, R., Olivares, M., & Sanz, Y. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115830 · Cited by 124
“LPS Gram-negative bacteria [212] CD14/TLR4 (enteric neurons, nodose ganglion neurons) Humoral pathway, gut nutrient sensing pathways (GLP-1 and potentially through vagal afferents) Reduction of food intake, enhancement of GLP-1-induced NO production in enteric neurons (possibly contributing to an anorexigenic shift in…”
BackgroundGeorgin, J., Franco, D. S. P., Ramos, C. G., Piccilli, D. G. A., Lima, E. C., & Sher, F. (2023) · Chemical Engineering Research and Design · doi:10.1016/j.cherd.2023.03.025 · Cited by 114
Reduced intestinal motility, mucosal barrier function, and inflammation in aged monkeys
Mitchell, E. L., Davis, A. T., Brass, K., Dendinger, M., Barner, R., Gharaibeh, R., Fodor, A. A., & Kavanagh, K. (2017) · The Journal of nutrition, health and aging · doi:10.1007/s12603-016-0725-y · Cited by 105
“Other “environmental factors” such as dietary fat and fructose, and obesity are known to increase MT and endotoxemia and thus confound human studies of aging and intestinal barrier function (19-21).”
BackgroundImpact of Brain Insulin Signaling on Dopamine Function, Food Intake, Reward, and Emotional Behavior
Kleinridders, A., & Pothos, E. N. (2019) · Current Nutrition Reports · doi:10.1007/s13668-019-0276-z · Cited by 117
Zhao, R., Long, X., Yang, J., Du, L., Zhang, X., Li, J., & Hou, C. (2019) · Food & Function · doi:10.1039/c9fo02077b · Cited by 110
Okubo, H., Sakoda, H., Kushiyama, A., Fujishiro, M., Nakatsu, Y., Fukushima, T., Matsunaga, Y., Kamata, H., Asahara, T., Yoshida, Y., et al. (2013) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00225.2013 · Cited by 106
Pierre, N., Deldicque, L., Barbé, C., Naslain, D., Cani, P. D., & Francaux, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0065061 · Cited by 105
“It has been reported that circulating LPS, the main TLR4 ligand, was increased after a HFD likely because of a more leaky gut [42,43,44].”
BackgroundSelf-citationSingh, D. P., Khare, P., Zhu, J., Kondepudi, K. K., Singh, J., Baboota, R. K., Boparai, R. K., Khardori, R. K., Chopra, K., & Bishnoi, M. (2015) · International Journal of Obesity · doi:10.1038/ijo.2015.197 · Cited by 110
Limbu, S. M., Ma, Q., Zhang, M., & Du, Z. (2019) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2019.05.067 · Cited by 106
From Maternal Diet to Neurodevelopmental Disorders: A Story of Neuroinflammation
Bordeleau, M., Fernández de Cossío, L., Chakravarty, M. M., & Tremblay, M.-È. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.612705 · Cited by 104
“While LPS has a physiological variation that peaks after feeding (Cani et al., 2008), persistent low-grade inflammation was observed after a mere 4 weeks of HFD consumption in adult mice (Cani et al., 2012).”
BackgroundInfluentialAntibiotics in the pathogenesis of diabetes and inflammatory diseases of the gastrointestinal tract
Fenneman, A. C., Weidner, M., Chen, L. A., Nieuwdorp, M., & Blaser, M. J. (2022) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-022-00685-9 · Cited by 117
Nutritional modulation of gut microbiota — the impact on metabolic disease pathophysiology
Ojeda, P., Bobe, A., Dolan, K., Leone, V., & Martinez, K. (2016) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2015.08.013 · Cited by 105
Zhou, X., Han, D., Xu, R., Li, S., Wu, H., Qu, C., Wang, F., Wang, X., & Zhao, Y. (2014) · PLoS ONE · doi:10.1371/journal.pone.0115148 · Cited by 105
“Late pathological observations showed islet atrophy and an overall reduction of in the number of islet cells, highlighting a progressive decline of secretive function, until secretory failure, which resulted in T2DM.”
BackgroundInfluentialWang, J.-H., Bose, S., Kim, H.-G., Han, K.-S., & Kim, H. (2015) · Scientific Reports · doi:10.1038/srep08391 · Cited by 104
Free Fatty Acids Profiles Are Related to Gut Microbiota Signatures and Short-Chain Fatty Acids
Rodríguez‐Carrio, J., Salazar, N., Margollés, A., González, S., Gueimonde, M., Reyes‐Gavilán, C. G. D. L., & Suárez, A. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00823 · Cited by 109
Cui, B., Su, D., Li, W., She, X., Zhang, M., Wang, R., & Zhai, Q. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1223-4 · Cited by 104
“Alterations in gut microbiota can lead to increased intestinal permeability associated with endotoxin absorption and consequently endotoxemia [44].”
TCA Cycle Rewiring as Emerging Metabolic Signature of Hepatocellular Carcinoma
Todisco, S., Convertini, P., Iacobazzi, V., & Infantino, V. (2019) · Cancers · doi:10.3390/cancers12010068 · Cited by 103
“Of note, HSCs as well as hepatocytes and KCs also express TLR4—the most important LPS receptor—and activate NF-κB pathway following changes in gut microbiota, increased intestinal permeability and raised blood levels of LPS in mice fed a high-fat diet [46].”
BackgroundDíez-Sainz, E., Milagro, F. I., Riezu‐Boj, J. I., & Lorente‐Cebrián, S. (2021) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-021-00837-6 · Cited by 123
Stasi, A., Cosola, C., Caggiano, G., Cimmarusti, M. T., Palieri, R., Acquaviva, P. M., Rana, G., & Gesualdo, L. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.925619 · Cited by 125
“In addition, dysbiosis leads to impairment of the gastrointestinal barrier with the release of endotoxins such as lipopolysaccharides (LPS) into the circulatory system (63) causing metabolic endotoxemia.”
BackgroundHan, Y., Ling, Q., Wu, L. M., Wang, X., Wang, Z., Chen, J., Zheng, Z., Zhou, Z., Jia, L., Li, L., et al. (2023) · Gut Microbes · doi:10.1080/19490976.2023.2221485 · Cited by 118
“A fluorescein isothiocyanate (FITC)-labeled dextran method.(56) was performed to evaluate intestinal barrier function in vivo.”
MethodBrignardello, J., Morales, P., Diaz, E., Romero, J., Brunser, O., & Gotteland, M. (2010) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2010.04475.x · Cited by 104
Enterotype Bacteroides Is Associated with a High Risk in Patients with Diabetes: A Pilot Study
Wang, J., Li, W., Wang, C., Wang, L., He, T., Hu, H., Song, J., Cui, C., Qiao, J., Qing, L., et al. (2020) · Journal of Diabetes Research · doi:10.1155/2020/6047145 · Cited by 103
“Based on previous studies regarding the gut microbiota and insulin resistance [24, 25], we assumed that the ET B was associated with increased intestinal permeability, which then resulted in a higher bacterial LPS concentration in the blood.”
BackgroundAre Obesity-Related Insulin Resistance and Type 2 Diabetes Autoimmune Diseases?
Tsai, S., Clemente-Casares, X., Revelo, X. S., Winer, S., & Winer, D. A. (2015) · Diabetes · doi:10.2337/db14-1488 · Cited by 103
“Elevated systemic endotoxin and other gut bacterial components can, in turn, trigger an inflammatory response through binding pattern recognition receptors, such as TLRs and nucleotide-binding oligomerization domain-containing protein (NOD) on innate immune cells and adipocytes alike to mediate insulin resistance (99,…”
BackgroundPhylotyping and Functional Analysis of Two Ancient Human Microbiomes
Tito, R. Y., Macmil, S., Wiley, G., Najar, F., Cleeland, L., Qu, C., Wang, P., Romagne, F., Leonard, S., Ruiz, A. J., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003703 · Cited by 104
“and diabetes [8–14].”
Interactions between inflammation, sex steroids, and Alzheimer’s disease risk factors
Uchoa, M. F., Moser, V. A., & Pike, C. J. (2016) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2016.09.001 · Cited by 102
“Microbiome imbalance leads to increased intestinal permeability, translocation of bacteria to the bloodstream, and systemic inflammation (Cani et al., 2008).”
Wang, L., Li, L., Lv, Y., Chen, Q., Feng, J., & Zhao, X. (2018) · Scientific Reports · doi:10.1038/s41598-018-20752-z · Cited by 123
Faecal Microbiota Are Related to Insulin Sensitivity and Secretion in Overweight or Obese Adults
Naderpoor, N., Mousa, A., Gómez-Arango, L. F., Barrett, H. L., Nitert, M. D., & de Courten, B. V. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8040452 · Cited by 110
“Importantly, reducing metabolic endotoxaemia, defined by elevated plasma LPS levels, with the use of antibiotics has been shown to improve glucose metabolism, adipose tissue inflammation, and weight gain in high-fat-fed mice [14].”
Background
Metadata
- Authors
- Cani, P. D., Bibiloni, R., Knauf, C., Waget, A., Neyrinck, A. M., Delzenne, N. M., & Burcelin, R.
- Affiliations
- UCLouvain (BE)
- Nestlé (Switzerland) (CH)
- Rangueil Institute of Molecular Medicine, Toulouse, France
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2008-06-01
- Volume
- 57
- Issue
- 6
- Pages
- 1470-1481
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W2129917444
- Cited by
- 4,819
- References
- 47
- Citations by year
- 2026: 223 · 2025: 240 · 2024: 305 · 2023: 319 · 2022: 397 · 2021: 420 · 2020: 389 · 2019: 396 · 2018: 368 · 2017: 319 · 2016: 319 · 2015: 292 · 2014: 199 · 2013: 187 · 2012: 149
- FWCI
- 40.09
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Diabetes (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Digital Access to Libraries (submittedVersion)
- Funders
- Agence Nationale de la Recherche (ANR-05-PNRA-004, ANR-05)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Dentistry › Periodontics › Oral microbiology and periodontitis research
- Keywords
- gut microbiota, metabolic endotoxemia, lipopolysaccharide, high-fat diet, obesity, type 2 diabetes, low-grade inflammation, antibiotic therapy, intestinal permeability, tight junctions, CD14, visceral adipose tissue, oxidative stress, impaired glucose tolerance, ob/ob mice
- MeSH terms
- Animals, Anti-Bacterial Agents, Bacteroides, Base Sequence, Bifidobacterium, Cecum, Crosses, Genetic, Diabetes Mellitus, Experimental, Feces, Female, Genotype, Inflammation, Lactobacillus, Male, Mice, Inbred C57BL, Mice, Obese, Obesity, RNA, Bacterial, Endotoxemia, Reverse Transcriptase Polymerase Chain Reaction, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.